Source: UT Southwestern University Summary: Researchers at have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.   More Information: Shaheen Khan et al, “Immune dysregulation in cancer patients developing immune-related adverse events”, British Journal of Cancer (2018). DOI: 10.1038/s41416-018-0155-1 Read More →

Hepatocellular carcinoma

Source: Cold Spring Harbor Laboratory Summary: Researchers reported that they have developed a method for identifying splicing-based biomarkers for the most common form of liver cancer, hepatocellular carcinoma (HCC). Hepatocellular carcinoma (HCC) is a liver cancer with symptoms including jaundice, weight loss, stomach pain, vomiting and yellowed skin. Because liver cancer is particularly diverse,Read More →

Macrophages play a role early metastasis

Source: The Mount Sinai Hospital Summary: Researchers have discovered that normal immune cells play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed. Cancer cell dissemination during early stages of breast cancer proceeds through poorly understoodRead More →